Is there an association between non-steroidal anti-inflammatory drugs and contrast nephropathy?;Há uma associação entre anti-inflamatórios não-esteroides e nefropatia induzida por contraste?

Arquivos Brasileiros de Cardiologia

Volumn 95, Issue 6, 2010, Pages 726-731

  Diogo, Luciano Passamani ^a   Saitovitch, David ^a   Biehl, Michelle ^d   Bahlis, Laura Fuchs ^c   Gutierres, Maria Claudia ^a   O'Keeffe, Cinthia Fonseca ^a   Carvalhal, Gustavo Franco ^a   Caramori, Paulo Ricardo Avancini ^a,b  

^a PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c HOSPITAL NOSSA SENHORA DA CONCEIÇÃO   (Brazil)

^d JACKSON MEMORIAL HOSPITAL   (United States)

Author keywords

Anti inflammatory agents, non steroid; Kidney diseases chemically induced; Risk factors

Indexed keywords

CREATININE; NONSTEROID ANTIINFLAMMATORY AGENT; RINGER LACTATE SOLUTION;

AGED; ARTICLE; CHRONIC KIDNEY FAILURE; COHORT ANALYSIS; CONTRAST INDUCED NEPHROPATHY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DISEASE COURSE; FEMALE; GLOMERULUS FILTRATION RATE; HEART CATHETERIZATION; HUMAN; HYDRATION; INTERVIEW; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; RISK FACTOR;

AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CONTRAST MEDIA; CREATININE; EPIDEMIOLOGIC METHODS; FEMALE; HEART CATHETERIZATION; HUMANS; MALE; RENAL INSUFFICIENCY;

EID: 79551598366     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: 10.1590/S0066-782X2010005000145     Document Type: Article

References (41)

1. Ultramari FT, Bueno RR, da Cunha CL, de Andrade PM, Nercolini DC, Tarastchuk JC, et al. Contrast media-induced nephropathy following diagnostic and therapeutic cardiac catheterization. Arq Bras Cardiol. 2006; 87 (3): 378-90.
2. Rao QA, Newhouse JH. Risk of nephropathy after intravenous administration of contrast material: a critical literature analysis. Radiology. 2006; 239 (2): 392-7.
3. Reddan D, Fishman EK. Radiologists' knowledge and perceptions of the impact of contrast-induced nephropathy and its risk factors when performing computed tomography examinations: a survey of European radiologists. Eur J Radiol. 2008; 66 (2): 235-45. (Pubitemid 351626392)
4. Rihal CS, Textor SC, Grill DE, Berger PB, Ting HH, Best PJ, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation. 2002; 105 (19): 2259-64.
5. McCullough PA, Wolyn R, Rocher LL, Levin RN, O'Neill WW. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med. 1997; 103 (5): 368-75. (Pubitemid 27506242)
6. Gleeson TG, Bulugahapitiya S. Contrast-induced nephropathy. AJR Am J Roentgenol. 2004; 183 (6): 1673-89.
7. Goldenberg I, Matetzky S. Nephropathy induced by contrast media: pathogenesis, risk factors and preventive strategies. CMAJ. 2005; 172 (11): 1461-71. (Pubitemid 40803495)
8. Barrett BJ, Parfrey PS, Vavasour HM, McDonald J, Kent G, Hefferton D, et al. Contrast nephropathy in patients with impaired renal function: high versus low osmolar media. Kidney Int. 1992; 41 (5): 1274-9.
9. Manske CL, Sprafka JM, Strony JT, Wang Y. Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography. Am J Med. 1990; 89 (5): 615-20. (Pubitemid 20384319)
10. Toprak O, Cirit M, Yesil M, Bayata S, Tanrisev M, Varol U, et al. Impact of diabetic and pre-diabetic state on development of contrast-induced nephropathy in patients with chronic kidney disease. Nephrol Dial Transplant. 2007; 22 (3): 819-26. (Pubitemid 46351691)
11. Rich MW, Crecelius CA. Incidence, risk factors, and clinical course of acute renal insufficiency after cardiac catheterization in patients 70 years of age or older: a prospective study. Arch Intern Med. 1990; 150 (6): 1237-42.
12. Lautin EM, Freeman NJ, Schoenfeld AH, Bakal CW, Haramati N, Friedman AC, et al. Radiocontrast-associated renal dysfunction: a comparison of lower-osmolality and conventional high-osmolality contrast media. AJR Am J Roentgenol. 1991; 157 (1): 59-65.
13. Barrett BJ, Parfrey PS, Vavasour HM, O'Dea F, Kent G, Stone E. A comparison of nonionic, low-osmolality radiocontrast agents with ionic, high-osmolality agents during cardiac catheterization. N Engl J Med. 1992; 326 (7): 431-6.
14. Goldfarb S, Spinler S, Berns JS, Rudnick MR. Low-osmolality contrast media and the risk of contrast-associated nephrotoxicity. Invest Radiol. 1993; 28 (Suppl 5): S7-10.
15. Harding MB, Davidson CJ, Pieper KS, Hlatky M, Schwab SJ, Morris KG, et al. Comparison of cardiovascular and renal toxicity after cardiac catheterization using a nonionic versus ionic radiographic contrast agent. Am J Cardiol. 1991; 68 (10): 1117-9.
16. Hill JA, Winniford M, Cohen MB, Van Fossen DB, Murphy MJ, Halpern EF, et al. Multicenter trial of ionic versus nonionic contrast media for cardiac angiography. The Iohexol Cooperative Study. Am J Cardiol. 1993; 72 (11): 770-5.
17. Hlatky MA, Morris KG, Pieper KS, Davidson CJ, Schwab SJ, Bashore TM. Randomized comparison of the cost and effectiveness of iopamidol and diatrizoate as contrast agents for cardiac angiography. J Am Coll Cardiol. 1990; 16 (4): 871-7.
18. Rudnick MR, Goldfarb S, Wexler L, Ludbrook PA, Murphy MJ, Halpern EF, et al. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study. Kidney Int. 1995; 47 (1): 254-61.
19. Toprak O, Cirit M, Bayata S, Yesil M, Aslan SL. The effect of pre-procedural captopril on contrast-induced nephropathy in patients who underwent coronary angiography. Anadolu Kardiyol Derg. 2003; 3 (2): 98-103. (Pubitemid 36798317)
20. Rudnick MR, Berns JS, Cohen RM, Goldfarb S. Contrast media-associated nephrotoxicity. Semin Nephrol. 1997; 17 (1): 15-26.
21. Rudnick MR, Kesselheim A, Goldfarb S. Contrast-induced nephropathy: how it develops, how to prevent it. Cleve Clin J Med. 2006; 73 (1): 75-80, 3-7.
22. Gambaro G, Perazella MA. Adverse renal effects of anti-inflammatory agents: evaluation of selective and nonselective cyclooxygenase inhibitors. J Intern Med. 2003; 253 (6): 643-52. (Pubitemid 36649096)
23. Palmer BF, Henrich WL. Clinical acute renal failure with nonsteroidal anti-inflammatory drugs. Semin Nephrol. 1995; 15 (3): 214-27.
24. Palmer BF, Henrich WL. Systemic complications of nonsteroidal antiinflammatory drug use. Adv Intern Med. 1996; 41: 605-39.
25. Venturini CM, Isakson P, Needleman P. Non-steroidal anti-inflammatory drug-induced renal failure: a brief review of the role of cyclo-oxygenase isoforms. Curr Opin Nephrol Hypertens. 1998; 7 (1): 79-82. (Pubitemid 28037525)
26. Agmon Y, Peleg H, Greenfeld Z, Rosen S, Brezis M. Nitric oxide and prostanoids protect the renal outer medulla from radiocontrast toxicity in the rat. J Clin Invest. 1994; 94 (3): 1069-75.
27. Breyer MD, Jacobson HR, Breyer RM. Functional and molecular aspects of renal prostaglandin receptors. J Am Soc Nephrol. 1996; 7 (1): 8-17.
28. Cantley LG, Spokes K, Clark B, McMahon EG, Carter J, Epstein FH. Role of endothelin and prostaglandins in radiocontrast-induced renal artery constriction. Kidney Int. 1993; 44 (6): 1217-23.
29. Dangas G, Iakovou I, Nikolsky E, Aymong ED, Mintz GS, Kipshidze NN, et al. Radiocontrast-induced acute renal failure - impact beyond the acute phase: contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables. Am J Cardiol. 2005; 95: 13-9,
30. J Am Soc Nephrol. 2006; 17 (3): 595-9.
31. Nolan CR, Anderson RJ. Hospital-acquired acute renal failure. J Am Soc Nephrol. 1998; 9 (4): 710-8.
32. Tepel M, Aspelin P, Lameire N. Contrast-induced nephropathy: a clinical and evidence-based approach. Circulation. 2006; 113 (14): 1799-806.
33. National Institute for Clinical Excellence (NICE). Technology Appraisal No. 27. Guidance on the use of cyclo-oxygenase (Cox) II selective inhibitors, celecoxib, rofecoxib, meloxicam and etodolac for osteoarthritis and rheumatoid arthritis.London; 2001. p. 18.
34. Rahme E, Joseph L, Kong SX, Watson DJ, LeLorier J. Gastrointestinal health care resource use and costs associated with nonsteroidal antiinflammatory drugs versus acetaminophen: retrospective cohort study of an elderly population. Arthritis Rheum. 2000; 43 (4): 917-24.
35. McIntosh E. The cost of rheumatoid arthritis. Br J Rheumatol. 1996; 35 (8): 781-90.
36. Blower AL, Brooks A, Fenn GC, Hill A, Pearce MY, Morant S, et al. Emergency admissions for upper gastrointestinal disease and their relation to NSAID use. Alimentary Pharmacology & Therapeutics. 1997; 11 (2): 283-91.
37. Lisse JR, Perlman M, Johansson G, Shoemaker JR, Schechtman J, Skalky CS, et al. Gastrointestinal tolerability and effectiveness of rofecoxib versus naproxen in the treatment of osteoarthritis: a randomized, controlled trial. Ann Intern Med. 2003; 139 (7): 539-46.
38. McCarthy CS, Becker JA. Multiple myeloma and contrast media. Radiology. 1992; 183 (2): 519-21.
39. Alamartine E, Phayphet M, Thibaudin D, Barral FG, Veyret C. Contrast medium-induced acute renal failure and cholesterol embolism after radiological procedures: incidence, risk factors, and compliance with recommendations. Eur J Intern Med. 2003; 14 (7): 426-31.
40. Brezis M, Heyman SN, Dinour D, Epstein FH, Rosen S. Role of nitric oxide in renal medullary oxygenation: studies in isolated and intact rat kidneys. J Clin Invest. 1991; 88 (2): 390-5.
41. Eisenberg RL, Bank WO, Hedgock MW. Renal failure after major angiography can be avoided with hydration. AJR Am J Roentgenol. 1981; 136 (5): 859-61.